Table 1 The UVM patient database from TCGA
From: TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma
Variables | All patients (n = 80) | Low expression (n = 40) | High expression (n = 40) | P value |
|---|---|---|---|---|
Gender | Â | Â | Â | 0.822 |
 Female | 35 (43.8%) | 17 (42.5%) | 18 (45.0%) |  |
 Male | 45 (56.2%) | 23 (57.5%) | 22 (55.0%) |  |
Age | Â | Â | Â | 0.653 |
 <60 | 36 (45.0%) | 17 (42.5%) | 19 (47.5%) |  |
  ≥ 60 | 44 (55.0%) | 23 (57.5%) | 21 (52.5%) |  |
Pathologic stage | Â | Â | Â | 0.025* |
 I & II | 36 (45.0%) | 23 (57.5%) | 13 (32.5%) |  |
 III & IV | 44 (55.0%) | 17 (42.5%) | 27 (67.5%) |  |
Histological type | Â | Â | Â | 0.05* |
 Epithelioid Cell | 13 (16.3%) | 3 (7.5%) | 10 (25.0%) |  |
 Mixed | 37 (46.2%) | 18 (45.0%) | 19 (47.5%) |  |
 Spindle Cell | 30 (37.5%) | 19 (47.5%) | 11 (27.5%) |  |
Type |  |  |  | < 0.001*** |
 metastatic | 19 (23.8%) | 5 (12.5%) | 14 (35.0%) |  |
 non-metastatic | 61 (76.3%) | 35 (87.5%) | 26 (65.0%) |  |
Statue | Â | Â | Â | 0.026* |
 Alive | 57 (71.3%) | 33 (82.5%) | 24 (60.0%) |  |
 Death | 23 (28.7%) | 7 (17.5%) | 16 (40.0%) |  |